[LEFT ATRIAL APPENDAGE CLOSURE IN A PATIENT WITH SYSTEMIC SCLEROSIS]

Insights

Systemic sclerosis patients with atrial fibrillation may experience gastrointestinal bleeding during anticoagulation. Percutaneous left atrial appendage closure offers an alternative to manage this bleeding risk.

Area of Science:

  • Cardiology
  • Gastroenterology
  • Rheumatology

Background:

  • Systemic sclerosis (scleroderma) can affect multiple organ systems, including the heart and gastrointestinal tract.
  • Chronic atrial fibrillation necessitates anticoagulant therapy, which can increase bleeding risks, particularly in patients with systemic sclerosis.

Observation:

  • A 69-year-old female with systemic sclerosis and chronic atrial fibrillation presented with recurrent gastrointestinal bleeding while on anticoagulation.
  • Percutaneous left atrial appendage closure was performed to address the bleeding complications.

Findings:

  • The case highlights the complex management of anticoagulation in patients with systemic sclerosis.
  • Percutaneous left atrial appendage closure is presented as a viable alternative for managing bleeding risks in specific clinical scenarios.

Implications:

  • This case underscores the need for individualized treatment strategies in patients with systemic sclerosis and atrial fibrillation.
  • Understanding the impact of scleroderma on cardiac and digestive systems is crucial for optimizing patient care and exploring alternative therapies like left atrial appendage closure.